Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering AM20061770

Client Email

Product

AM20061770
US Patents

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

AM20061770

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 26 USDMF, 9 CEP/COS, 11 JDMF, 17 EU WC, 26 KDMF, 15 NDC API, 13 Listed Suppliers, $ API Reference Price

45 API Suppliers
26 USDMF
9 CEP/COS
11 JDMF
17 EU WC
26 KDMF
15 NDC API
13 Listed Suppliers
$ API Reference Price

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

3 API Suppliers

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

160 FDF Dossiers, 77 FDA Orange Book, 36 Europe, 15 Canada, 2 South Africa, 30 Listed Dossiers

160 FDF Dossiers
77 FDA Orange Book
36 Europe
15 Canada
2 South Africa
30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 15MG BASE, TABLET;ORAL - EQ 30MG BASE, TABLET;ORAL - EQ 45MG BASE, TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 850MG;EQ 15MG BASE, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE

TABLET;ORAL - EQ 15MG BASE
TABLET;ORAL - EQ 30MG BASE
TABLET;ORAL - EQ 45MG BASE
TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 850MG;EQ 15MG BASE
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 16 SPI Pharma, 2 Seqens, 4 DKSH, 2 Jai Radhe Sales, 6 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 27 BASF, 2 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

87 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 41 Direct Compression, 32 Disintegrants & Superdisintegrants, 32 Controlled & Modified Release, 27 Solubilizers, 27 Thickeners and Stabilizers, 26 Granulation, 21 Co-Processed Excipients, 20 Parenteral, 20 Lubricants & Glidants, 20 Topical, 18 Film Formers & Plasticizers, 17 Taste Masking, 15 Chewable & Orodispersible Aids, 9 Emulsifying Agents, 8 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules

87 Fillers, Diluents & Binders
54 Coating Systems & Additives
41 Direct Compression
32 Disintegrants & Superdisintegrants
32 Controlled & Modified Release
27 Solubilizers
27 Thickeners and Stabilizers
26 Granulation
21 Co-Processed Excipients
20 Parenteral
20 Lubricants & Glidants
20 Topical
18 Film Formers & Plasticizers
17 Taste Masking
15 Chewable & Orodispersible Aids
9 Emulsifying Agents
8 API Stability Enhancers
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 17 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
17 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 18 Finished Drug Prices

2 US Medicaid Prescriptions
18 Finished Drug Prices

MARKET PLACE

11 APIs, 1 FDF Dossiers

11 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

36 US Patents, 9 Health Canada Patents

36 US Patents
9 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 6 JP, 1 Others

2 EDQM
2 USP
6 JP
1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 386 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

36 All

01 36TAKEDA PHARMS USA

filter Patent Number Reset all filters

36 All

01 27700128

02 27785627

03 67807689

04 27959946

05 28071130

06 68173663

07 68288539

08 68637079

09 29101660

10 29320714

filter API Patent Reset all filters

36 All

01 12Y

02 24Blank

filter FDF Patent Reset all filters

36 All

01 24Y

02 12Blank

filter Expiration Date Reset all filters

36 All

01 122025-03-15

02 42026-07-31

03 22027-01-22

04 22027-01-30

05 22028-06-08

06 62028-06-27

07 22029-02-03

08 62029-06-04

US Patents
Health Canada Patents

Product Main Page

01

TAKEDA PHARMS USA

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

TAKEDA PHARMS USA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-03-15

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 8173663

Drug Substance Claim :

Drug Product Claim :

Application Number : 22426

Patent Use Code : U-1338

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2025-03-15

Portfolio PDF

Product Web Link

Digital Content

02

TAKEDA PHARMS USA

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

TAKEDA PHARMS USA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-03-15

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 8173663

Drug Substance Claim :

Drug Product Claim :

Application Number : 22426

Patent Use Code : U-1338

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2025-03-15

Portfolio PDF

Product Web Link

Digital Content

03

TAKEDA PHARMS USA

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

TAKEDA PHARMS USA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-03-15

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 8173663

Drug Substance Claim :

Drug Product Claim :

Application Number : 22426

Patent Use Code : U-1338

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2025-03-15

Portfolio PDF

Product Web Link

Digital Content

04

TAKEDA PHARMS USA

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

TAKEDA PHARMS USA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-27

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 7807689

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22426

Patent Use Code : U-1337

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2028-06-27

Portfolio PDF

Product Web Link

Digital Content

05

TAKEDA PHARMS USA

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

TAKEDA PHARMS USA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-03-15

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 8173663

Drug Substance Claim :

Drug Product Claim :

Application Number : 22426

Patent Use Code : U-1338

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2025-03-15

Portfolio PDF

Product Web Link

Digital Content

06

TAKEDA PHARMS USA

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

TAKEDA PHARMS USA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-03-15

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 8173663

Drug Substance Claim :

Drug Product Claim :

Application Number : 22426

Patent Use Code : U-1338

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2025-03-15

Portfolio PDF

Product Web Link

Digital Content

07

TAKEDA PHARMS USA

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

TAKEDA PHARMS USA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-27

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 7807689

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22426

Patent Use Code : U-1337

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2028-06-27

Portfolio PDF

Product Web Link

Digital Content

08

TAKEDA PHARMS USA

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

TAKEDA PHARMS USA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-03-15

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 8173663

Drug Substance Claim :

Drug Product Claim :

Application Number : 22426

Patent Use Code : U-1338

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2025-03-15

Portfolio PDF

Product Web Link

Digital Content

09

TAKEDA PHARMS USA

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

TAKEDA PHARMS USA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-27

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 7807689

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22426

Patent Use Code : U-1337

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2028-06-27

Portfolio PDF

Product Web Link

Digital Content

10

TAKEDA PHARMS USA

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

TAKEDA PHARMS USA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-27

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

US Patent Number : 7807689

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22426

Patent Use Code : U-1337

Delist Requested :

Patent Use Description : METHOD OF TREATING DIA...

Patent Expiration Date : 2028-06-27

Portfolio PDF

Product Web Link

Digital Content

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?